Global Negative Pressure Wound Therapy Market Size was valued at USD 2.47 Bn in 2023 and is predicted to reach USD 4.11 Bn by 2031 at a 6.8% CAGR during the forecast period for 2024 to 2031. Negative Pressure Wound Therapy Market Size, Share & Trends Analysis Report, By Product Type (Conventional NPWT Devices, Disposable NPWT Devices, NPWT Accessories), By Wound Type (Burns and Surgical Open Wounds, Pressure Ulcers, Diabetic Foot Ulcers...
Report ID: 2838 |
Delivery: Immediate |
Published: October 2024 |
No. of Pages: 167
Global Retinoic Acid Pathway Therapeutics Market Size is predicted to grow at an 7.4% CAGR during the forecast period for 2024-2031. The Retinoic Acid Pathway Therapeutics Market Size, Share & Trends Analysis Distribution by Product Type (Retinoic Acid Receptor Agonists (RAR Agonists), Retinoid X Receptor Agonists (RXR Agonists), RAR and RXR Dual Agonists, Others (Novel/Next-Generation Retinoic Acid Derivatives)), Application, Route of Admin...
Report ID: 2816 |
Delivery: Immediate |
Published: October 2024 |
No. of Pages: 170
The Synthetic Blood Substitute Market Size is valued at USD 7.26 Bn in 2023 and is predicted to reach USD 20.75 Bn by the year 2031 at an 14.3% CAGR during the forecast period for 2024-2031. The global synthetic blood substitute industry is rapidly evolving, focusing on the development of artificial blood products to overcome the limitations of traditional blood transfusions. These substitutes aim to address issues such as blood type compatibi...
Report ID: 2798 |
Delivery: Immediate |
Published: September 2024 |
No. of Pages: 170
The Catastrophic Antiphospholipid Syndrome Market Size was valued at USD 4.38 Bn in 2023 and is predicted to reach USD 9.34 Bn by 2031 at a 10.2% CAGR during the forecast period for 2024-2031. Catastrophic antiphospholipid syndrome refers to an uncommon immunological condition marked by persistent antiphospholipid antigens, chronic arterial or venous embolism, and reproductive mortality. It is more common in women and may develop as eithe...
Report ID: 2786 |
Delivery: Immediate |
Published: September 2024 |
No. of Pages: 165
The Longevity and Anti-Senescence Therapy Market Size is valued at USD 2,736.43 million in 2023 and is predicted to reach USD 4,121.54 million by the year 2030 at a 6.8 % CAGR during the forecast period for 2024-2030. Longevity is an effective approach focuses on the extension of health span by slowing the rate of aging. This approach is considered as the most efficient way to combat various aging-related chronic illnesses and disabling condit...
Report ID: 1354 |
Delivery: Immediate |
Published: September 2024 |
No. of Pages: 185
The Oligonucleotide Delivery System Market is predicted to grow at an 12.4% CAGR during the forecast period for 2024-2031. The delivery system of an oligonucleotide refers to the method and technologies applied for transferring oligonucleotides into cells where they could exert their therapeutic effects. Oligonucleotides, due to their size and chemical properties, face the challenge of penetration through the biological barriers to enter targe...
Report ID: 2779 |
Delivery: Immediate |
Published: September 2024 |
No. of Pages: 165
The Lipid-Based Drug Delivery Systems Market Size is predicted to grow with a an CAGR of 11.9% during the forecast period for 2024-2031. Lipid-based drug delivery systems (LBDDS) are intended to increase the delivery and efficacy of drugs that are poorly soluble in water. These systems employ lipids as carriers to promote drug bioavailability, resulting in greater absorption in the body. LBDDS are employed in a variety of pharmaceutical applic...
Report ID: 2764 |
Delivery: Immediate |
Published: September 2024 |
No. of Pages: 180
The Bioactive Formulation for Functional F&B Market is predicted to grow at an 8.31% CAGR during the forecast period for 2024-2031. Bioactive formulations in functional food and beverages (F&B) utilize biologically active compounds that provide health benefits beyond basic nutrition. These formulations typically include ingredients such as polyphenols, prebiotics, probiotics, vitamins, peptides, and dietary fibers, which are targeted at...
Report ID: 2736 |
Delivery: Immediate |
Published: September 2024 |
No. of Pages: 180
The Non-Sterile Outsourcing Market Size is valued at USD 7.50 Bn in 2023 and is predicted to reach USD 10.81 Bn by the year 2031 at an 4.8% CAGR during the forecast period for 2024-2031. A compounded medication product can be either non-sterile or sterile and contains one or more active ingredients. While it is possible to manufacture compounded sterile products internally, an alternative is to contract with a 503B outsourcing facility outside...
Report ID: 2740 |
Delivery: Immediate |
Published: September 2024 |
No. of Pages: 178
The GMP Biologics Market Size is valued at USD 52.3 Bn in 2023 and is predicted to reach USD 153.9 Bn by the year 2031 at an 14.6% CAGR during the forecast period for 2024-2031. The term "Good Manufacturing Practice" (GMP) Biologics describes the manufacture of biologic pharmaceuticals by strict legal requirements intended to guarantee the effectiveness, safety, and quality of the final product. The World Health Organization (WHO) and other or...
Report ID: 2715 |
Delivery: Immediate |
Published: August 2024 |
No. of Pages: 165
Pharmaceuticals